{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-032628","form_type":"8-K","ticker":"ACUT","cik":"0001850767","company_name":"Accustem Sciences Inc.","filed_at":"2022-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.739786+00:00","generated_at":"2026-06-21T17:45:10.240668+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"AccuStem Sciences appoints Sean McDonald as independent director; board now five members","bullets":["Sean McDonald appointed to AccuStem board effective Nov. 14, 2022; board expanded from four to five members.","McDonald currently CEO of Ocugenix, a therapeutics company focusing on ocular diseases.","He previously scaled Automated Healthcare (acquired by McKesson) and served as CEO of Precision Therapeutics.","McDonald was a director at Respironics before its $5.1B acquisition by Philips."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-032628","json":"https://secwatch.observer/filing/0001493152-22-032628.json","markdown":"https://secwatch.observer/filing/0001493152-22-032628.md","text":"https://secwatch.observer/filing/0001493152-22-032628.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850767/000149315222032628/0001493152-22-032628-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850767/000149315222032628/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T17:45:10.240668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e1bec5ff27","claim":"Sean McDonald was elected as independent director at Accustem Sciences Inc..","evidence_excerpt":"On November 14, 2022, the Board of Directors (the “Board”) of AccuStem Sciences, Inc. (the “Company”) increased the size of the Board to five members and elected Sean McDonald as an independent director, for a term continuing to the Company’s next annual meeting of shareholders, when all directors will be subject to election by shareholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850767/000149315222032628/0001493152-22-032628-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"independent director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}